Market Research Report New Study provides Vaginal Atrophy Global Pipeline

New Study provides Vaginal Atrophy Global Pipeline
Overview and Therapeutic Landscape, H2 2016
No of Pages – 52
Publishing Date - November, 2016
Browse detailed TOC, Tables, Figures, and Charts in Global Serial Device Server Consumption
2016 Market Research Report at:
http://www.marketresearchhub.com/report/vaginal-atrophy-atrophic-vaginitis-pipeline-review-h2-2016report.html
Vaginal atrophy is thinning, drying and inflammation of the vaginal walls due to body having less
estrogen. Signs and symptoms include vaginal dryness, vaginal discharge, genital itching, burning
with urination, and urgency with urination, urinary tract infections and urinary incontinence. Risk
factor includes smoking. Smoking impairs blood circulation, depriving the vagina and other tissues
of oxygen. Tissue thinning occurs where blood flow is decreased or restricted.

Vaginal Atrophy pipeline guide helps in identifying and tracking emerging players in the market
and their portfolios, enhances decision making capabilities and helps to create effective counter
strategies to gain competitive advantage. The guide is built using data and information sourced
from Global Markets Directs proprietary databases, company/university websites, clinical trial
registries, conferences, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources. Additionally, various dynamic
tracking processes ensure that the most recent developments are captured on a real time basis.